Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)

  1. Lopez-Pascual, A.
  2. Russo-Cabrera, J.S.
  3. Ardaiz, N.
  4. Palmer, T.
  5. Graham, A.-R.
  6. Uriarte, I.
  7. Gomar, C.
  8. Ruiz-Guillamon, D.
  9. Latasa, M.U.
  10. Arechederra, M.
  11. Fontanellas, A.
  12. Monte, M.J.
  13. Marin, J.J.G.
  14. Berasain, C.
  15. Del Rio, C.L.
  16. Fernandez-Barrena, M.G.
  17. Martini, P.G.V.
  18. Schultz, J.R.
  19. Berraondo, P.
  20. Avila, M.A.
Aldizkaria:
Clinical science (London, England : 1979)

ISSN: 1470-8736

Argitalpen urtea: 2024

Alea: 138

Zenbakia: 20

Orrialdeak: 1265-1284

Mota: Artikulua

DOI: 10.1042/CS20241137 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus